Citation: | CHEN Ye, DING Jinxi, LIU Ting, TANG Di, WU Fang, WU Liping, DUAN Wanting, XU Yangyan. Status, problems and improvement measures of health insurance reimbursement of national negotiated drugs used in outpatients[J]. Journal of China Pharmaceutical University, 2020, 51(5): 628-634. DOI: 10.11665/j.issn.1000-5048.20200516 |
[1] |
.[
|
[2] |
National Health Commission of the People''''s Republic of China. Publication of the first list of rare diseases(关于公布第一批罕见病目录的通知)[EB/OL].[
|
[3] |
NHSA. Four national ministries jointly issued the Guiding Opinions on Improving the Medical Insurance Mechanism for Outpatient Use of Hypertension and Diabetes in Urban and Rural Residents(四部门印发《关于完善城乡居民高血压糖尿病门诊用药保障机制的指导意见》)[EB/OL].[
|